Hand holding the newspaper resting on a table with a cup of coffee

Newsroom

Taxonomy Icon
  • May 26, 2020
The Ivy Brain Tumor Center at Barrow Neurological Institute announced that patient recruitment has opened for a Phase 0 clinical trial to evaluate two targeted therapy drugs, abemaciclib and LY3214996. The study will evaluate central nervous system (CNS) penetration in patients with recurrent glioblastoma scheduled for resection. This is the first time a combination of these two drugs will be tested in brain tumor patients.
Taxonomy Icon
  • April 3, 2020
  • Source: Office of Governor Ducey
“It’s very important to me that the medical personnel in this state have the right tools and supplies to fight this battle,” said Catherine Ivy, co-founder of the Ivy Brain Tumor Center.
Taxonomy Icon
  • February 28, 2020
  • Source: Barrow Neurological Institute
Barrow Neurological Institute neurosurgeon, Dr. Zaman Mirzadeh has received a three-year, $1.8 million grant from the U.S. Department of Defense (DoD) to study the rewiring of the brain to normalize blood sugar levels in diabetes. As a member of the Ivy Center team, Dr. Mirzadeh runs a lab focused on identifying unique metabolic pathways co-opted by glioblastoma to drive tumor growth.
Taxonomy Icon
  • February 28, 2020
  • Source: Oncology Times
The Ivy Brain Tumor Center at the Barrow Neurological Institute is a nonprofit center conducting early phase clinical trials of new therapeutics for brain tumors. In this interview with Oncology Times, Dr. Nader Sanai explains how the phase 0 trials work and why the center is so excited about them.
Taxonomy Icon
  • January 14, 2020
The Ivy Brain Tumor Center at Barrow Neurological Institute has announced a partnership with two East Valley hospitals to expand its novel Phase 0 clinical trials program, the first of its kind in neuro-oncology.
Taxonomy Icon
  • January 2, 2020
  • Source: PharmaVoice
Catherine Ivy, who lost her husband a decade ago to a devastating and sudden brain cancer, shares her personal journey of grief and purpose, which led to the founding of the Ivy Brain Tumor Center at the Barrow Neurological Institute.
Taxonomy Icon
  • December 23, 2019
  • Source: Cancer Today
Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.
Taxonomy Icon
  • November 23, 2019
  • Source: The Onco'Zine Brief
In this edition of The Onco’Zine Brief, Peter Hofland talks with Catherine Ivy about how after losing her husband Ben to glioblastoma she became a tireless advocate for brain cancer patients.
Taxonomy Icon
  • November 21, 2019
  • Source: Onco'Zine - The International Oncology Network
The Ivy Brain Tumor Center at the Barrow Neurological Institute and SonALASense have signed an strategic agreement to jointly test a new and non-invasive drug-device combination, called sonodynamic therapy or SDT, for the treatment of recurrent glioblastoma.
Taxonomy Icon
  • November 21, 2019
The Ivy Brain Tumor Center at the Barrow Neurological Institute, today announced a strategic collaboration with SonALASense to develop and test a new, non-invasive drug-device combination, sonodynamic therapy (SDT), for recurrent glioblastoma through a Phase 0/2 clinical trial.